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Abstract
Background: Cytosine-phosphate-guanine (CpG) oligodeoxyribonucleotides (ODNs) are synthetic DNA fragments
containing unmethylated cytosine-guanine motifs with potential immune modulatory effects and have recently been
suggested to enhance sensitivity to traditional therapies in lung cancer. This study aimed to examine the effects of
CpG ODN1826 on transforming growth factor-beta 1(TGF-β1) and radiation-induced pulmonary fibrosis in mice.
Methods: The radiation-induced pulmonary fibrosis mouse model was established by a single dose of 20 Gy, 6 MV
X-rays exposure to the left lung. ICR mice were evenly randomized into four groups, comprising: a control group, a
radiation group (RT group), a CpG group and a radiation combined with CpG ODN1826 group (RT + CpG group), with
40 mice in each group. CpG ODN1826 was intraperitoneally injected into mice at 1, 3, 5, 7 and 9 d post-irradiation. The
mice were sacrificed at 1, 5, 15, 30 and 90 d post-irradiation. Paraffin sections of the radiated lung were subjected to
H&E staining and Masson staining. The Ashcroft scale was used for quantitative histological analysis of fibrotic changes
induced by irradiation. Concentrations of serum TGF-β1 were determined by ELISA, and concentrations of
Hydroxyproline(Hyp) in the lung were determined with the alkaline hydrolysis method. Relative gene expression of
FoxP3 was determined by real-time PCR.
Results: The radiation-induced pulmonary fibrosis mouse model was successfully established. The serum concentrations
of TGF -β1 of RT group were higher than those of the RT + CpG group (t = 5.212, 7.126, 7.972 and 3.785, P < 0.05). The
Hyp in the lung of RT group was higher than that of RT + CpG group (t = 4.606, P < 0.05). The relative expressions of
FoxP3 gene in the lung of the RT group were higher than those of RT + CpG group (t = 8.395, 5.099 and 6.147, P < 0.05).
Conclusions: CpG ODN1826 could reduce the serum concentrations of TGF-β1 and the lung content of Hyp in
radiation-induced pulmonary fibrosis, which might be related to the possibility that CpG ODN1826 can reduce
expression of the FoxP3 gene.
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Background
Radiation therapy is one of the most important treat-
ments for the chest tumors, but common complica-
tions from such treatments include radioactive lung
injuries and dose-limiting side effects [1]. Radiation-
induced pulmonary fibrosis is the main pathological
process of late radiation induced lung injury [2].
TGF-β1, which plays an important role in the process
of starting and developing pulmonary fibrosis, has
been acknowledged as the most important cytokine to
reflect pulmonary fibrosis severity [3]. The FoxP3
gene is one of the important genes regulating the
secretion of TGF-β1, and FoxP3 gene expression can
reduce the secretion of TGF-β1. CpG oligodeoxynucleo-
tides (ODNs) are synthetic DNA sequences containing
unmethylated cytosine-guanine motifs, which were
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identified by activating TLR9 in antigen-presenting cells
and B cells, and CpG ODNs can activate the active
immune cells to produce a variety of cytokines which
enhance the body’s specific and nonspecific immune effect
and prevent a potential microbial infection [4]. CpG can
improve the microenvironment in some malignant
tumors, such as lung cancer and liver cancer, and reduce
the TGF-β1 concentration in the microenvironment [5, 6].
Therefore, CpG might also reduce the TGF-β1 concentra-
tion in radiation-induced pulmonary fibrosis disease. In
this study, we observed the effects of CpG on radiation-
induced pulmonary fibrosis, detected the effects of CpG
on the serum TGF-β1 and preliminary explored if this
effect was related to the CpG FoxP3 gene.
Methods
Experimental animals and reagents
One hundred and sixty ICR female mice were provided
by the Shanghai Experimental Animal Center and main-
tained in a specific pathogen-free grade animal room until
6–8 weeks of age and weighing 18–22 g. The study was
approved by the ethics committee of Jinshan Hospital of
Fudan University. CpG ODN1826 was purchased from
Shanghai Biological Engineering Technology and Service
Limited Company (Shanghai, China). CpG ODN1826 was
completely phosphorothioate-modified and purified with
PAGE gel. The sequence of CpG ODN1826 was: 5′-TCC
ATG ACG TTC CTG ACG TT-3′. CpG ODN1826 was
diluted in PBS to a concentration of 0.1 mg/ml. The real
time PCR primer sequences for FoxP3 were: upstream
primer: 5′-TTCACCTATGCCACCCTTATCC-3′, down-
stream primer: 5′-GCGAAACTCAAATTCATCTACGG-
3′; GAPDH: upstream primer: 5′-GCCTTCCGTGTTC
CTACC-3′, downstream primer: 5′- AGAGTGGGAG
TTGCTGTTG-3′. Mouse serum TGF-β1 ELISA kit was
provided by R&D Company from USA. Masson Trichro-
matic staining kit and hydroxyproline (Hyp) kit were pro-
vided by Nanjing Kaiji Biological Science and Technology
Limited Company (Nanjing, China). ReverTra Ace®qPCR
RT kit was provided by TOYOBO Company from Japan,
Trizol from Invitrogen Company from USA and Rever-
tAid TMFirst strand cDNA Synthesis kit from Fermentas
Company from Canada. A linear accelerator was used
(Precise 5839, Elekta, Stockholm, Sweden).
Experimental groups
One hundred and sixty ICR mice were evenly random-
ized into four groups: (1) Control group: intraperitoneal
injection of 0.2 ml saline. (2) RT group: intraperitoneal
injection of the same saline with single left lung 20 Gy
of 6 MV X-ray. (3) CpG group: intraperitoneal injection
of 0.1 mg/ml concentration CpG ODN1826 solution
0.2 ml. (4) RT + CpG group: intraperitoneal injection of
the same CpG ODN1826, with single left lung 20 Gy of
6 MV X-ray. The first injections were performed 12 h
after radiation, which was defined as day 1. The saline
and CpG ODN1826 groups were all injected on day 1, 3,
5, 7 and 9. Six mice of each group were sacrificed on
day 1, 5, 15, 30 and eight mice on day 90.
Radiation-induced pulmonary fibrosis mouse model
Before irradiation, mice were anesthetized by injecting in-
traperitoneal 4 μl/g body mass of 10 % chloral hydrate.
The mice were immobilized and shielded under a home-
made device. After accurate positioning of the irradiation
area of mice with the simulator, a single dose of 20Gy of 6
MV X-rays was delivered to a 2 cm× 2 cm area in the left
lung at a rate of 2.0 Gy/min. Non-irradiated mice under-
went the same procedure but were not exposed to
radiation.
Histologic analysis and pulmonary fibrosis scoring
Lung tissues were dissected at different time points and
fixed in formalin. The tissues were then embedded in par-
affin and sectioned. After H&E staining or Masson stain-
ing, pulmonary fibrosis was observed under an optical
microscope. The Ashcroft scale was used for the quantita-
tive histologic analysis of fibrotic changes induced by ir-
radiation. Pulmonary fibrosis was scored double blinded
under the optical microscope. The pulmonary fibrosis was
scored as follows: 0, normal; 1, a little fibrosis of alveolar
bronchiole wall; 2–3, moderate fibrosis and no structural
changes of alveolar wall; 4–5, alveolar structure changes
and fibers; 6–7, serious alveolar structure changes and
massive fibrosis; 8, totally fibrosis [7]. Each sample was
scored with 9 horizons randomly, and the average score of
each group was calculated.
Detecting the serum TGF-β1 and Hyp concentrations in
the radiated mouse lung tissues
Mouse blood samples were collected under institute
approved protocols and incubated at room temperature
for 30 min to allow the blood to clot. The blood samples
were then centrifuged at 3000 rpm for 15 min. Sera were
then collected and diluted 60-fold to test TGF-β1
concentrations by ELISA. Hyp concentrations in the
radiated lung tissues were determined with the alkaline
hydrolysis method. Briefly, freshly irradiated lung tissue
was hydrolyzed with an accurate scale under the PH at
6.0–6.8. The supernatant was collected after centrifuga-
tion. The absorbance of each sample was measured with
a light spectrophotometer under 550 nm and Hyp
concentration of each sample was calculated.
Expression of FoxP3 gene in the irradiated mouse lungs
Total RNA samples were isolated from flash-frozen left
lung tissues of the mice from each group with Trizol by
following the manufacturer’s instructions. First strand
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cDNA was synthesized with the reverse transcription kit.
Relative mRNA expression of the FoxP3 gene was
assayed by quantitative real time PCR with gene specific
primers with GAPDH as internal control.
Statistical analysis
Statistical analysis was performed by SPSS21.0 (IBM).
Data were expressed as means ± standard deviation (SD).
Single factor analysis of variance test was used to test the
differences between groups. The multiple comparisons
were evaluated by the Bonferroni method. The non-
parametric statistic test (Wald-Wolfowitz test) was used
to test for differences between RT group and RT + CpG
group on pulmonary fibrosis scores. Differences resulting
in P < 0.05 were considered to be statistically significant.
Results
CpG reduced radiation-induced pulmonary fibrosis
We observed the structural changes of bronchi, alveoli
and alveolar interval organization under the optical
microscope. Figure 1a a e c g and Fig. 1b a c showed the
bronchi, alveoli and alveolar interval structure of the
pseudo irradiation groups were normal, with no chronic
inflammation change and pulmonary fibrosis. Therefore,
the pulmonary fibrosis scores of Control and CpG
groups were zero. Pulmonary fibrosis of RT and RT +
CpG groups were not observed on day 5 and 15.
Figure 1a b showed part of the fiber cells and collagen
fiber hyperplasia, a lot of neutrophils and mononuclear
macrophage infiltration, and inflammatory cells gathered
around secondary bronchi and blood vessels in the RT
group on day 30. Figure 1a d showed the RT + CpG
group exhibited less pulmonary hemorrhage, the fiber
cells and collagen fiber hyperplasia, neutrophils and
mononuclear macrophage infiltration than the RT group
on day 30. Figure 1a f and Fig. 1b b showed the red
blood cells and inflammatory cells infiltration of the RT
group on day 90 were reduced, but part of the alveolar
cavity disappeared, alveolar wall fractured and a large
number of fiber cells proliferated and collagen fibers
were deposited in the alveolar interval. Figure 1a h and
Fig. 1b d showed basic alveolar structure in the RT +
CpG group was normal, with regional focal fibrosis
nodules, and less fiber cell proliferation and collagen
Fig. 1 a Left lung tissue paraffin section with HE staining (×200); a: Control group days 30 after irradiation; b: RT group days 30 after irradiation;
c: CpG group days 30 after irradiation; d: RT + CpG group days 30 after irradiation; e: Control group days 90 after irradiation; f: RT group days 90
after irradiation; g: CpG group days 90 after irradiation; h: RT + CpG group days 90 after irradiation. b Left lung tissue section with Masson staining
(×200); a: Control group days 90 after irradiation; b: RT group days 90 after irradiation; c: CpG group days 90 after irradiation; d: RT + CpG group
days 90 after irradiation. Abbreviations: CpG, cytosine-guanine; RT, irradiation
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deposition observed between alveolus on day 90. The
results in Fig. 2 showed the pulmonary fibrosis score of
RT group was higher than that of RT + CpG group on
day 30 and 90. And the difference was statistically
significant on day 90 (P < 0.05). This data indicates CpG
may play a protective role in radiation-induced pulmon-
ary fibrosis.
CpG ODN1826 reduced serum TGF-β1 concentrations in
irradiated mice
TGF-β1 plays a vital role in the initiation and progres-
sion of pulmonary fibrosis, and has been acknowledged
as the most important cytokine to reflect the severity of
pulmonary fibrosis [3]. The results in Table 1 showed
serum TGF-β1 concentrations in mice increased after
irradiation, and the highest point was detected on day
30. The serum TGF-β1 concentrations of the RT + CpG
group were lower than those of the RT group on day 5,
15, 30 and 90 (P < 0.05). From the results, we found that
CpG could reduce the serum TGF-β1 concentrations in
radiation-induced pulmonary fibrosis mice.
CpG ODN1826 decreased concentrations of Hyp in the
irradiated mouse lung
During the progression of radiation-induced pulmonary
fibrosis, the main sedimentary composition are collagen
fibers [8]. Hyp is characteristic of collagen fiber, and it is
commonly used to reflect the degree of radiation-
induced pulmonary fibrosis [9]. From the pathological
sections, we observed that the radiation-induced
pulmonary fibrosis was most severe on day 90 after ir-
radiation. We therefore measured Hyp concentrations in
the radiated lung tissues in mice on day 90 to quantify
the degree of radiation-induced pulmonary fibrosis. The
results in Table 2 showed the radiated lung tissues
concentrations of Hyp in mice increased on day 90.
The Hyp concentration in radiated lung tissue of the
RT + CpG group was lower than that of the RT group
(P < 0.05). This result was consistent with the results
observed in the pathological sections. These data
together with those obtained from the pathological
sections suggest that CpG could reduce sedimentary
collagen fiber in irradiated lungs, and alleviate
radiation-induced pulmonary fibrosis.
CpG treatment down regulates FoxP3 expression in
irradiated lung
The FoxP3 gene is one of the important genes in
regulating the secretion of TGF-β1, and studies have
confirmed that FoxP3 gene expression can reduce the
secretion of TGF-β1 [10–12]. The relative expressions of
FoxP3 was analyzed by real-time PCR. The results in
Table 3 showed that the relative expression quantity of
FoxP3 in irradiated lung increased after radiation. The
relative expression quantity of FoxP3 in the RT + CpG
group was lower than that in the RT group (P < 0.05).
The results demonstrate CpG treatment down-regulates
FoxP3 expression in irradiated lungs, and this may be
the reason that CpG ODN1826 could reduce the serum
concentration of TGF-β1 of radiation-induced pulmon-
ary fibrosis mouse.
Discussion and conclusions
CpG oligodeoxynucleotides (ODNs) are synthetic DNA
sequences containing unmethylated cytosine–guanine
motifs, which activate TLR9, and CpG ODNs can acti-
vate many kinds of immune cells [4]. CpG ODNs can
cause the differentiation of B cells, stimulate B cells to
secrete cytokines IL-6 and IL-10, and prevent apoptosis
of B cells [13]. In cooperation with IL-12, CpG ODNs
can activate NK cells directly to secrete IFN-γ, which in
turn, can further promote the activation of monocytes,
macrophages and dendritic cells [14]. At present, the re-
search of the CpG as immune adjuvant is thorough. In
the CpG ODN auxiliary hepatitis b vaccine clinical trials,
researchers found that CpG ODN can effectively activate
the body’s immune system to produce the cellular and
humoral immune response with the hepatitis b vaccine,
and found no obvious toxic effects [15, 16]. It has been
proven that CpG ODNs can treat infectious diseases,
cancer and allergic diseases [17–19]. For example, a
study found that protamine nanoparticles with CpG-
oligodeoxynucleotide prevent an allergen-induced
Th2-response in BALB/c mice [20]. Our previous
experiments gave mice ODN1826 through intraperito-
neal injection on day 1, 3, 5, 7 and 9, and found that
CpG ODN1826 has obvious radio-sensitization effects
to lung cancer, and no obvious cytotoxicity was found
[21]. Radiation-induced pulmonary fibrosis is the
main pathological process of the late radiation in-
duced lung injury [2]. In the early damage, inflamma-
tory mediators secretion increased continuously,
causing alveolar exudates to increase, pulmonary
Fig. 2 The scores of pulmonary fibrosis on day 30 and 90. Notes:
*P < 0.05, RT versus RT + CpG on days 30 and 90. Abbreviations: CpG,
cytosine-guanine; RT, irradiation
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interstitial hyperemia edema and inflammatory reac-
tion cells infiltration. In the late damage, an exception
repairing and tissue remodeling occurred, muscle
fibroblasts increased, which resulted collagen depos-
ition and fibrosis [8, 22].
Recent studies suggest that the pathological morpho-
logical changes of radiation-induced lung injury mainly
include pulmonary interstitial hyperemia and edema, an
increase in alveolar exudates, inflammatory cells infiltra-
tion, late fiber connective tissue hyperplasia and alveolar
atrophy [23, 24]. The H&E staining and Masson staining
of paraffin sections showed the radiation-induced
pulmonary fibrosis mouse model was clearly established
in this study. CpG ODN1826 could reduce fiber cell pro-
liferation and collagen deposition. Hyp accounts for
13.4 % of collagen and is often used to reflect pulmonary
fibrosis [9]. Our study found that CpG ODN1826 could
reduce the Hyp content of the exposed lung. From these
results, we posit that CpG ODN1826 might ameliorate
pulmonary fibrosis caused by irradiation.
TGF-β is the growth regulating factor for the epithelial
origin cells in human, and has extensive biological
effects in cell growth, differentiation, extracellular matrix
deposition and the immune reaction of the body [25].
TGF-β1, one of the subtypes of TGF-β, has been ac-
knowledged as the most important cytokine to result the
fibrosis in late injury, which can not only induce the
fibroblast around the bronchioles branch and vascular
into myofibroblasts, but also induce the normal lung
epithelial cells into myofibroblasts, and thus play an
important role in the process of fibrosis [26, 27]. CpG
ODNs may affect the secretion of various cytokines.
However, the effect of CpG ODN1826 to TGF-β1 and
radiation-induced pulmonary fibrosis is unknown. Our
study found that the serum TGF-β1 concentrations in
mice increased after irradiation, and the highest point
we detected was on day 30. However, the serum
TGF-β1 concentration of the RT + CpG group was
lower than that of the RT group, suggesting CpG
ODN1826 could reduce the serum concentration of
TGF-β1 after irradiation. CD4+/CD25+ Treg, which
has the function of regulating the immune system, is
a T cell subgroup, and is an important factor for the
secretion of TGF-β1 [28]. FoxP3 is the most specific
symbol of CD4+/CD25+ Treg, and the key regulatory
gene in the development and functions to maintain
CD4+/CD25+ Treg [29]. One study has found that
CpG ODNs could inhibit the expression of the FoxP3
gene, and reduce the proportion of CD4+/CD25+
Treg, and thus down-regulate the serum TGF-β con-
centration in lung cancers [5]. Our study found that
the expression of the FoxP3 in mice increased after
irradiation, but the expression of the FoxP3 in RT +
CpG group was lower than that of irradiation group.
Therefore, CpG ODN1826 could reduce the serum
concentration of TGF-β1 of radiation-induced
pulmonary fibrosis mouse, which might be due to its
effect on reduction of FoxP3 gene expression. Com-
pared with the control group, FoxP3 gene was down-
regulated in the CpG group. However, as shown in
Table 1, no significant difference was observed in the
TGF-β1 expression of CpG group and the control
group. One of the possible explanations is that CpG,
Table 1 The serum TGF-β1 at different times (days) (ng/ml, x þ s)
Group Mice(n) 1 d 5 d 15 d 30 d 90 d
Control 6 107.511 ± 10.032 103.027 ± 11.797 117.598 ± 16.270 108.595 ± 17.082 123.615 ± 17.491















Notes: F = 4.959, P < 0.05 on days 1; F = 23.1, P < 0.05 on days 5; F = 51.743, P < 0.05 on days 15; F = 114.643, P < 0.05 on days 30; F = 30.874, P < 0.05 on days 90;
aP < 0.05 versus control at t = 5.318, 9.432, 11.103, 15.298, 5.913, 6.260, 4.822 and 8.197; bP < 0.05 versus RT at t = 5.212, 7.126, 7.972 and 3.785; cP < 0.05 versus
CpG at t = 4.546, 11.034, 16.263, 8.692, 5.573, 8.448 and 6.167
Abbreviations: CpG cytosine-guanine, RT irradiation, n number, d days
Table 2 The lung tissue concentrations of Hyp on day 90
(μg/mg, x þ s)
Group Mice(n) 90 d
Control 8 1.137 ± 0.087







Notes: F = 57.470, P < 0.05; aP < 0.05 versus control at t = 7.847 and 6.003;
bP < 0.05 versus RT at t = 4.606; cP < 0.05 versus CpG at t = 7.867 and 5.778
Abbreviations: CpG cytosine-guanine, RT irradiation, n number, d days
Table 3 Relative expressions of FoxP3 at different times (days)
(2-△CT△CT, x þ s)
Group Mice(n) 5 d 15 d 30 d
Control 6 1.000 ± 0.181 1.000 ± 0.105 1.000 ± 0.135











Notes: F = 155.5, P < 0.05 on days 5; F = 96.553, P < 0.05 on days15; F = 102.525,
P < 0.05 on days 30; aP < 0.05 versus control at t = 11.224, 9.115, 9.214, 6.072,
7.661, and 4.521; bP < 0.05 versus RT at t = 8.395, 5.099 and 6.147; cP < 0.05
versus control at t = 19.182, 12.833, 14.709, 21.585, 16.807 and 13.228
Abbreviations: CpG cytosine-guanine, RT irradiation, n number, d days
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as an immunopotentiator, exerts its effect on balan-
cing T1/T2 immune cells. The mechanisms of how
Foxp3 regulates TGF-β1 expression are still not fully
understood. Peng et al. found that CD4 + CD25 +
FoxP3+ Tregs attenuate TGF-β1 induced lung fibrosis
and fibrocyte accumulation in part via suppression of
FGF-9 [11]. Sumitomo et al. found that transcription
factor early growth response 3 is a key factor associ-
ated with TGF-β1 expression regulated by FoXp3
[12]. Other than downregulation of FoxP3 gene ex-
pression, CpG might balance the secretion of TGF-β1
via some other mechanism. In addition, there are also
many other factors may affect TGF-β1 expression. For
example, Molteni et al. found that angiotensin had an im-
portant regulatory role on TGF-β1, and it promoted the
secretion of TGF-β1 in the process of radiation-induced
lung injury [30]. Jain found that plasma endothelin-1
could stimulate the secretion of TGF-β1 in the study of
idiopathic pulmonary fibrosis [31]. We will therefore take
further steps to elucidate the mechanism in our future
studies. In conclusion, our study found that CpG
ODN1826 could partly prevent radiation-induced pul-
monary fibrosis, and reduce the serum concentration of
TGF-β1 of radiation-induced pulmonary fibrosis, which
might be related to the reduced expression of the FoxP3
gene. This finding indicatives a significant potential for
the clinical application of CpG ODNs in treatment of the
radiation-induced pulmonary fibrosis.
Abbreviations
CpG ODN1826: CpG oligodeoxynucleotide 1826; Hyp: hydroxyproline;
TGF-β1: transforming growth factor-beta 1.
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